The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19
- PMID: 33298301
- PMCID: PMC7545305
- DOI: 10.1016/j.jsat.2020.108163
The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19
Abstract
Historically, federal and state policies have narrowly defined treatment models that have resulted in limited access to and engagement in counseling for individuals receiving medications for opioid use disorder (MOUD; e.g., methadone and buprenorphine). In response to the coronavirus pandemic, outpatient MOUD treatment providers rapidly transitioned from traditional, in-person care delivery models to revised COVID-19 protocols that prioritized telehealth counseling to protect the health of patients and staff and ensure continuity in MOUD care. These telehealth innovations appear to mitigate many of the longstanding barriers to counseling in the traditional system and have the potential to forever alter MOUD care delivery. Drawing on data from a Rhode Island-based clinic, we argue that MOUD counseling is achievable via telehealth and outline the need for, and anticipated benefits of, hybrid telehealth/in-person MOUD treatment models moving forward.
Keywords: COVID-19; Counseling; MOUD; Opioid use disorder; Telehealth.
Copyright © 2020 Elsevier Inc. All rights reserved.
References
-
- Briere J., Spinazzola J. 2009. Assessment of the sequelae of complex trauma. Treating complex traumatic stress disorders: An evidence-based guide; pp. 104–123.
-
- Brooks E., Turvey C., Augusterfer E.F. Provider barriers to telemental health: Obstacles overcome, obstacles remaining. Telemedicine and e-Health. 2013;19(6):433–437. - PubMed
-
- Center for Disease Control and Prevention Coronavirus Disease 2019 (COVID-19): People who are at higher risk for severe illness. 2020. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-...
-
- Eibl J.K., Gauthier G., Pellegrini D., Daiter J., Varenbut M., Hogenbirk J.C., Marsh D. The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting. Drug and Alcohol Dependence. 2017;176:133–138. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
